Literature DB >> 9727390

New types of liposidomycins that inhibit bacterial peptidoglycan synthesis and are produced by Streptomyces. I. Producing organism and medium components.

K Kimura1, S Kagami, Y Ikeda, H Takahashi, M Yoshihama, H Kusakabe, H Osada, K Isono.   

Abstract

Liposidomycins are atypical lipid-bearing nucleoside antibiotics that inhibit bacterial peptidoglycan synthesis. A producing strain was identified as a Streptomyces sp. from its cultural characteristics and physiological properties. It produced new types of liposidomycins that lacked sulfate and/or 3-methylglutaric acid moieties present in known liposidomycins by changing medium components. Sucrose and malt extract were particularly suitable sources for specific production of the new types of liposidomycins.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9727390     DOI: 10.7164/antibiotics.51.640

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  2 in total

Review 1.  Structures of Bacterial MraY and Human GPT Provide Insights into Rational Antibiotic Design.

Authors:  Ellene H Mashalidis; Seok-Yong Lee
Journal:  J Mol Biol       Date:  2020-03-19       Impact factor: 5.469

2.  Chemical logic of MraY inhibition by antibacterial nucleoside natural products.

Authors:  Ellene H Mashalidis; Benjamin Kaeser; Yuma Terasawa; Akira Katsuyama; Do-Yeon Kwon; Kiyoun Lee; Jiyong Hong; Satoshi Ichikawa; Seok-Yong Lee
Journal:  Nat Commun       Date:  2019-07-02       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.